These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2360916)

  • 1. Effects of lovastatin therapy on LDL receptor activity in circulating monocytes and on structure and composition of plasma lipoproteins.
    Raveh D; Israeli A; Arnon R; Eisenberg S
    Atherosclerosis; 1990 May; 82(1-2):19-26. PubMed ID: 2360916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of lovastatin on concentrations and composition of lipoprotein subfractions.
    Nozaki S; Vega GL; Haddox RJ; Dolan ET; Grundy SM
    Atherosclerosis; 1990 Oct; 84(2-3):101-10. PubMed ID: 2282090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profiles.
    Helve E; Tikkanen MJ
    Atherosclerosis; 1988 Aug; 72(2-3):189-97. PubMed ID: 3063268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lovastatin in the treatment of primary hypercholesterolemia].
    Broda G; Rywik S; Chotkowska E; Bednarek M; Kuzmińska A; Polakowska M
    Kardiol Pol; 1991; 35(8):84-9. PubMed ID: 1942761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia.
    O'Malley JP; Illingworth DR
    Metabolism; 1990 Feb; 39(2):150-4. PubMed ID: 2299987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up.
    Ojala JP; Helve E; Karjalainen K; Tarkkanen A; Tikkanen MJ
    Atherosclerosis; 1990 May; 82(1-2):85-95. PubMed ID: 2360923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of lovastatin treatment on low-density lipoprotein hydrated density distribution and composition in patients with intermittent claudication and primary hypercholesterolemia.
    Tilly-Kiesi M
    Metabolism; 1991 Jun; 40(6):623-8. PubMed ID: 1865826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemia.
    Jacob BG; Möhrle W; Richter WO; Schwandt P
    Eur J Clin Pharmacol; 1992; 42(4):353-8. PubMed ID: 1516599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia.
    Thiery J; Creutzfeldt C; Creutzfeldt W; Walli AK; Seidel D
    Klin Wochenschr; 1990 Aug; 68(16):814-22. PubMed ID: 2214604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: lack of effect on low-density lipoprotein concentrations or turnover.
    Uauy R; Vega GL; Grundy SM; Bilheimer DM
    J Pediatr; 1988 Aug; 113(2):387-92. PubMed ID: 3397806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of LDL receptors and response to lovastatin therapy in familial homozygotic hypercholesterolemia].
    Ausina Gómez A; Gilsanz Peral A; Montero Brens C; Dalmau Serra J
    An Esp Pediatr; 1991 Nov; 35(5):327-31. PubMed ID: 1785747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal cholesterol levels with lovastatin (mevinolin) therapy in a child with homozygous familial hypercholesterolemia following liver transplantation.
    East C; Grundy SM; Bilheimer DW
    JAMA; 1986 Nov; 256(20):2843-8. PubMed ID: 3534334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia.
    Clauss SB; Holmes KW; Hopkins P; Stein E; Cho M; Tate A; Johnson-Levonas AO; Kwiterovich PO
    Pediatrics; 2005 Sep; 116(3):682-8. PubMed ID: 16140708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin.
    Arca M; Vega GL; Grundy SM
    JAMA; 1994 Feb; 271(6):453-9. PubMed ID: 8295321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative hypolipidemic effects of lovastatin and simvastatin in patients with heterozygous familial hypercholesterolemia.
    Illingworth DR; Bacon S; Pappu AS; Sexton GJ
    Atherosclerosis; 1992 Sep; 96(1):53-64. PubMed ID: 1418102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein fractions and receptors: a role for probucol?
    Bilheimer DW
    Am J Cardiol; 1986 Jun; 57(16):7H-15H. PubMed ID: 3637051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism.
    Carmena R; Roederer G; Mailloux H; Lussier-Cacan S; Davignon J
    Metabolism; 1993 Jul; 42(7):895-901. PubMed ID: 8345800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of lovastatin on serum lipids in patients with primary hyperlipidemia and phenotype IIa and IIB. II. Changes of lipid composition of plasma lipoprotein fractions after lovastatin administration].
    Idzior-Waluś B
    Przegl Lek; 1992; 49(10):327-33. PubMed ID: 1308286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia.
    Leren TP; Hjermann I; Berg K; Leren P; Foss OP; Viksmoen L
    Atherosclerosis; 1988 Oct; 73(2-3):135-41. PubMed ID: 3056429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.